SCHEMBL412673

SCHEMBL412673

CCCCCCCCCCCCCC[n+]1ccn(CC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.48
ESR1 P03372 1/20 0.48
PGR P06401 1/20 0.48
CHRM2 P08172 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CHRM1 P11229 1/20 0.48
DRD1 P21728 1/20 0.48
TBXA2R P21731 1/20 0.48
ACHE P22303 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
PDE4A P27815 1/20 0.48
SLC6A4 P31645 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL898690 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL5291584 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL413382 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL898377 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL899147 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL409128 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL5287687 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL5302535 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL5288768 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL28402105 1.00 ABCB11 (0.48) ABCB11ESR1PGRCHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107835841-B Crystallization-retarded polymer composition, additive composition influencing crystallization behavior and use, method for reducing crystallization point 弗劳恩霍弗应用研究促进协会 2021-01-05 CN claimed
US-10781296-B2 Polymer composition having delayed crystallization behavior, additive composition that influences the crystallization behavior, method for lowering the crystallization point, and use of an additive composition Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2020-09-22 US claimed
CN-111117220-A Polyamide composition with permanent static dissipation function and application thereof 会通新材料(上海)有限公司 2020-05-08 CN claimed
EP-3313938-B1 POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION FRAUNHOFER GES FORSCHUNG (DE) 2019-08-07 EP claimed
US-20180186970-A1 POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2018-07-05 US claimed
EP-3313938-A1 POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION Fraunhofer Gesellschaft zur Förderung der Angewand (DE) 2018-05-02 EP claimed
WO-2016207003-A1 POLYMER COMPOSITION HAVING DELAYED CRYSTALLIZATION BEHAVIOR, ADDITIVE COMPOSITION THAT INFLUENCES THE CRYSTALLIZATION BEHAVIOR, METHOD FOR LOWERING THE CRYSTALLIZATION POINT, AND USE OF AN ADDITIVE COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2016-12-29 WO claimed
EP-2440693-B1 USE OF IONIC FLUIDS FOR PRETREATING PLASTIC SURFACES FOR METALLIZATION BASF SE (DE) 2016-08-10 EP claimed
US-8993660-B2 Antistatic thermoplastic compositions BASF SE (DE) 2015-03-31 US claimed
EP-2242744-B1 Process for working up ionic liquids BASF SE (DE) 2014-06-25 EP claimed
EP-2602023-A1 Catalyst combination for the preparation of polyurethane foams BASF SE (DE) 2013-06-12 EP claimed
US-20120283367-A1 ANTISTATIC THERMOPLASTIC COMPOSITIONS BASF SE (DE) 2012-11-08 US claimed
EP-2509459-A1 ANTISTATIC THERMOPLASTIC COMPOSITIONS BASF SE (DE) 2012-10-17 EP claimed
WO-2011069960-A1 ANTISTATIC THERMOPLASTIC COMPOSITIONS BASF SE (DE) 2011-06-16 WO claimed
WO-2006077082-A1 METHOD FOR SEALING ROTATING SHAFTS BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 WO claimed
EP-4703496-A1 ETCHING COMPOSITION COMPRISING AT LEAST ONE IONIC LIQUID AND AT LEAST ONE LACTAMIDE AND PROCESS FOR COATING PLASTIC SURFACES WITH METALS BY USING THE SAME BASF SE (DE) 2026-03-04 EP disclosed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
WO-2006108861-A2 SOLUBILITY OF CELLULOSE IN IONIC LIQUIDS WITH ADDITION OF AMINO BASES BASF AKTIENGESELLSCHAFT (DE) 2006-10-19 WO disclosed
WO-2006077082-A1 METHOD FOR SEALING ROTATING SHAFTS BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 WO disclosed
WO-2005113702-A1 NOVEL PAIRS OF WORKING SUBSTANCES FOR ABSORPTION HEAT PUMPS, ABSORPTION REFRIGERATION MACHINES AND HEAT TRANSFORMERS BASF AKTIENGESELLSCHAFT (DE) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM ABCB11 1678/4885ESR1 3156/4885PGR 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.